Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,538 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of 12-Month Angioscopic Thrombi and Yellow Plaque After Drug-Eluting Stent Implantation.
Nishino M, Egami Y, Nohara H, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Okamoto N, Matsunaga-Lee Y, Yano M, Shiraki T, Nakamura D, Mizote I, Ishihara T, Mano T, Ueno T, Nakatani D, Hikoso S, Nanto S, Sakata Y; COLLABORATION Investigators. Nishino M, et al. Among authors: ueno t. Circ J. 2024 Oct 25;88(11):1758-1767. doi: 10.1253/circj.CJ-24-0255. Epub 2024 Jul 11. Circ J. 2024. PMID: 38987207 Free article.
Co-occurrence of Neuromyelitis Optica Spectrum Disorder and Idiopathic Multicentric Castleman Disease Successfully Treated with Tocilizumab: A Case Report.
Tsuzuki Wada T, Yokota K, Okada M, Ichimura T, Ueno T, Okumura N, Osawa I, Inoue K, Akiyama Y, Nakazato Y, Sasaki A, Yamamoto T, Mimura T. Tsuzuki Wada T, et al. Among authors: ueno t. Intern Med. 2024 Dec 26. doi: 10.2169/internalmedicine.4503-24. Online ahead of print. Intern Med. 2024. PMID: 39721693 Free article.
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world study.
Aoyama Y, Ozaki Y, Kizawa R, Masuda J, Kawai S, Kurata M, Maeda T, Yoshida K, Yamashita N, Nishimura M, Hosonaga M, Fukada I, Hara F, Kobayashi T, Takano T, Ueno T. Aoyama Y, et al. Among authors: ueno t. Breast Cancer. 2024 Dec 7. doi: 10.1007/s12282-024-01657-4. Online ahead of print. Breast Cancer. 2024. PMID: 39644440
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial.
Rediti M, Venet D, Joaquin Garcia A, Maetens M, Vincent D, Majjaj S, El-Abed S, Di Cosimo S, Ueno T, Izquierdo M, Piccart M, Pusztai L, Loi S, Salgado R, Viale G, Rothé F, Sotiriou C. Rediti M, et al. Among authors: ueno t. Nat Commun. 2024 Nov 29;15(1):10402. doi: 10.1038/s41467-024-54621-3. Nat Commun. 2024. PMID: 39613746 Free PMC article.
3,538 results